+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Indaptus Therapeutics

INDPNASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$2.02

-0.11-5.16%

After Hours: Jul 18, 7:53 PM EDT

15 minutes delayed

Indaptus Therapeutics (INDP) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Indaptus Therapeutics (NASDAQ:INDP) Stock

Indaptus Therapeutics Stock (NASDAQ: INDP)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, June 17, 2024

HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk

Tuesday, June 11, 2024

Indaptus Therapeutics To Present At STING & T...
Benzinga Newsdesk

Friday, June 07, 2024

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Tuesday, June 04, 2024

Indaptus Therapeutics To Present New Positive...
Benzinga Newsdesk

Monday, June 03, 2024

Indaptus Therapeutics Announces New Data From...
Benzinga Newsdesk

Wednesday, May 29, 2024

Indaptus Therapeutics Presents New Cohort Dat...
Benzinga Newsdesk

Wednesday, May 22, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Indaptus Therapeutics shares are trading high...
Benzinga Newsdesk
Indaptus Therapeutics First Patient Received ...
Benzinga Newsdesk

Wednesday, May 08, 2024

Indaptus Therapeutics Q1 EPS $(0.45) Misses $...
Benzinga Newsdesk

Thursday, May 02, 2024

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights

Wednesday, May 01, 2024

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Monday, April 15, 2024

HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk

Thursday, April 11, 2024

Indaptus Therapeutics Unveils Details On Mech...
Benzinga Newsdesk

Friday, April 05, 2024

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Monday, March 25, 2024

Indaptus Therapeutics Previews Mechanism Of A...
Benzinga Newsdesk

Wednesday, March 13, 2024

Indaptus Therapeutics: Q4 Earnings Insights
Benzinga Insights
Indaptus Therapeutics FY EPS $(1.83) Beats $(...
Benzinga Newsdesk

Monday, March 11, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Monday, March 04, 2024

Indaptus Therapeutics Announces Results From ...
Benzinga Newsdesk

Thursday, February 29, 2024

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Thursday, February 08, 2024

Indaptus Therapeutics Launches Social Media C...
Benzinga Newsdesk

Thursday, January 04, 2024

European Patent Office Approves Patent For In...
Benzinga Newsdesk

Monday, November 06, 2023

Indaptus Therapeutics Q3 EPS $(0.47) Beats $(...
Benzinga Newsdesk
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Indaptus Therapeutics shares are trading high...
Benzinga Newsdesk
Indaptus Therapeutics Announces Interim Data ...
Benzinga Newsdesk

Tuesday, October 31, 2023

Indaptus Therapeutics To Present Pharmacodyna...
Benzinga Newsdesk

Wednesday, September 20, 2023

HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk

Tuesday, September 19, 2023

Indaptus Therapeutics Doses First Patient In ...
Benzinga Newsdesk

Thursday, August 17, 2023

Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Lisa Levin

Tuesday, August 15, 2023

HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk

Monday, August 14, 2023

Indaptus Therapeutics Q2 EPS $(0.39) Beats $(0.58) Estimate
Happy Mohamed

Friday, August 11, 2023

HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk

Thursday, August 10, 2023

Indaptus Therapeutics Announces Opening Of Next Cohort In Single Dose Ranging Study Of Decoy20
Happy Mohamed

Tuesday, August 08, 2023

Chief Medical Officer at Indaptus Therapeutics Acquires Company Stock Options Worth 90,000 Shares
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk

Wednesday, May 10, 2023

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Tuesday, May 09, 2023

Following Granting Of Indian Patent, Indaptus Therapeutics Achieves Patent Protection In 32 Countries For Decoy Immunotherapy Platform
Happy Mohamed

Thursday, May 04, 2023

What 4 Analyst Ratings Have To Say About Indaptus Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk

Wednesday, April 19, 2023

Indaptus Therapeutics Says Antitumor Platform Demonstrates Preclinical Efficacy Across Cancer Indications
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Indaptus Therapeutics Highlights Presentation...
Benzinga Newsdesk

Monday, April 17, 2023

Indaptus Therapeutics Receives Brazilian Pate...
Benzinga Newsdesk

Monday, March 20, 2023

HC Wainwright & Co. Maintains Buy on Indaptus...
Benzinga Newsdesk

Friday, March 17, 2023

Indaptus Therapeutics Q4 EPS $(0.44) Vs $(0.5...
Happy Mohamed
Indaptus Therapeutics FY EPS $(1.73) Beats $(...
Benzinga Newsdesk

Wednesday, March 08, 2023

HC Wainwright & Co. Reiterates Overweight on ...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved